-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Eledon Pharmaceuticals, Inc. quarterly and annual Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Dec 2017 to 31 Mar 2025.
- Eledon Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2025 was $3,892,000, a 60% decline year-over-year.
- Eledon Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $70,314,000, a 55% decline from 2023.
- Eledon Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $45,287,000.
- Eledon Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was $11,035,000.